Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Liquid biopsy in cancer.

Salinas Sánchez AS, Martinez Sanchis C, Gimenez Bachs JM, García Olmo DC.

Actas Urol Esp. 2016 Jan-Feb;40(1):1-2. doi: 10.1016/j.acuro.2015.06.008. Epub 2015 Aug 18. English, Spanish. No abstract available.

PMID:
26296278
2.

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

Anker P, Mulcahy H, Stroun M.

Int J Cancer. 2003 Jan 10;103(2):149-52. Review. No abstract available.

3.

Liquid biopsy: Potential and challenges.

Pantel K, Alix-Panabières C.

Mol Oncol. 2016 Mar;10(3):371-3. doi: 10.1016/j.molonc.2016.01.009. Epub 2016 Feb 1. No abstract available.

4.

Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Gold B, Cankovic M, Furtado LV, Meier F, Gocke CD.

J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001. Review.

5.

Circulating nucleic acids (CNAs) and cancer--a survey.

Fleischhacker M, Schmidt B.

Biochim Biophys Acta. 2007 Jan;1775(1):181-232. Epub 2006 Oct 7. Review.

PMID:
17137717
6.

Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.

Gahan PB.

Infect Disord Drug Targets. 2008 Jun;8(2):100-8. Review.

PMID:
18537705
7.

Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?

Bunn PJ Jr.

J Clin Oncol. 2003 Nov 1;21(21):3891-3. Epub 2003 Sep 24. Review. No abstract available.

PMID:
14507944
8.

RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.

Silva J, Silva JM, García V, García JM, Domínguez G, Bonilla F.

Genes Chromosomes Cancer. 2002 Dec;35(4):375-6. No abstract available.

PMID:
12378534
9.

[Present status and perspectives of tumor markers].

Kuroki M.

Nihon Rinsho. 2005 Apr;63 Suppl 4:585-91. Review. Japanese. No abstract available.

PMID:
15861715
10.

Liquid cancer biopsy: the future of cancer detection?

The Lancet Oncology.

Lancet Oncol. 2016 Feb;17(2):123. doi: 10.1016/S1470-2045(16)00016-4. No abstract available.

PMID:
26868335
11.

Circulating nucleic acids in cancer and pregnancy.

Pinzani P, Salvianti F, Pazzagli M, Orlando C.

Methods. 2010 Apr;50(4):302-7. doi: 10.1016/j.ymeth.2010.02.004. Epub 2010 Feb 8. Review.

PMID:
20146940
12.

Liquid Biopsy Holds Its Own in Tumor Profiling.

[No authors listed]

Cancer Discov. 2016 Jul;6(7):686. doi: 10.1158/2159-8290.CD-NB2016-070. Epub 2016 Jun 10.

13.

Platelet RNA signatures for the detection of cancer.

Sol N, Wurdinger T.

Cancer Metastasis Rev. 2017 Jun;36(2):263-272. doi: 10.1007/s10555-017-9674-0. Review.

14.

Diagnostic potential of circulating nucleic acids for oncology.

Goessl C.

Expert Rev Mol Diagn. 2003 Jul;3(4):431-42. Review.

PMID:
12877383
15.

[High-molecular forms of DNA in the blood serum of rats with Zaidel's hepatoma].

Grikurova NK, Belokhvostov AS, Seĭts IF.

Vopr Onkol. 1983;29(4):70-3. Russian.

PMID:
6190316
16.

Circulating nucleic acids in plasma and serum: past, present and future.

Taback B, Hoon DS.

Curr Opin Mol Ther. 2004 Jun;6(3):273-8. Review.

PMID:
15264429
17.

Robustness of comprehensive DNA- and RNA-based assays at diagnosis of acute myeloid leukemia using blood and bone marrow stored on filter cards.

Haferlach T, Weber S, Konietschke R, Nadarajah N, Stengel A, Kern W, Haferlach C, Meggendorfer M.

Leukemia. 2016 Oct;30(10):2123-2125. doi: 10.1038/leu.2016.156. Epub 2016 May 25. No abstract available.

PMID:
27220669
18.

The tumour trail left in blood.

Chi KR.

Nature. 2016 Apr 14;532(7598):269-71. doi: 10.1038/532269a. No abstract available.

PMID:
27075102
19.

Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.

Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I, Inoue T.

Cancer Sci. 2009 Feb;100(2):303-9. doi: 10.1111/j.1349-7006.2008.01021.x.

20.

Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.

Schlange T, Pantel K.

Pharmacogenomics. 2016 Feb;17(3):183-6. doi: 10.2217/pgs.15.163. Epub 2016 Jan 22. No abstract available.

Supplemental Content

Support Center